DAVID PLEDGER LYLE
Allopathic & Osteopathic Physicians|Family Medicine LEXINGTON, SC NPI 1154339331
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine SC Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$7,580.21
- Category: General Payments
- Program years: PY2018–2024
- Record count: 496
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,613.10 across 70 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,613.10 | 70 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $457.80 | 1 |
| Novo Nordisk AS | $151.84 | 9 |
| Lilly USA, LLC | $138.17 | 9 |
| ABBVIE INC. | $137.99 | 11 |
| DEXCOM, INC. | $110.58 | 3 |
| GlaxoSmithKline, LLC. | $88.07 | 5 |
| PFIZER INC. | $79.52 | 5 |
| Abbott Laboratories | $63.86 | 4 |
| Corcept Therapeutics | $57.19 | 4 |
| Acerta Pharma LLC | $56.28 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.44 | 2 |
| Exact Sciences Corporation | $38.14 | 2 |
| Merck Sharp & Dohme Corporation | $35.17 | 2 |
| Astellas Pharma US Inc | $33.36 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.32 | 2 |
| Sumitomo Pharma America, Inc. | $28.37 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.89 | 1 |
| CVRx Inc. | $16.23 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.41 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.47 | 1 |
By program year
Records — PY2024 (70)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.